Cite
Exogenous pancreatic kininogenase protects against tacrolimus-induced renal injury by inhibiting PI3K/AKT signaling: The role of bradykinin receptors.
MLA
Ding, Jun, et al. “Exogenous Pancreatic Kininogenase Protects against Tacrolimus-Induced Renal Injury by Inhibiting PI3K/AKT Signaling: The Role of Bradykinin Receptors.” International Immunopharmacology, vol. 105, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2022.108547.
APA
Ding, J., Jin, J., Na Lei, Y., Cui, S., Ying Li, H., Lan Zheng, H., Guo Piao, S., Ji Jiang, Y., Ying Xuan, M., Zhe Jin, J., Shun Jin, Y., Pyo Lee, J., Ha Chung, B., Soon Choi, B., Woo Yang, C., & Li, C. (2022). Exogenous pancreatic kininogenase protects against tacrolimus-induced renal injury by inhibiting PI3K/AKT signaling: The role of bradykinin receptors. International Immunopharmacology, 105, N.PAG. https://doi.org/10.1016/j.intimp.2022.108547
Chicago
Ding, Jun, Jian Jin, Yan Na Lei, Sheng Cui, Hui Ying Li, Hai Lan Zheng, Shang Guo Piao, et al. 2022. “Exogenous Pancreatic Kininogenase Protects against Tacrolimus-Induced Renal Injury by Inhibiting PI3K/AKT Signaling: The Role of Bradykinin Receptors.” International Immunopharmacology 105 (April): N.PAG. doi:10.1016/j.intimp.2022.108547.